Patents Assigned to Leukemia Therapeutics, LLC
  • Identification of novel diagnostics and therapeutics by modulating RhoH
    Patent number: 10746739
    Abstract: The disclosure relates to identifying novel therapeutic targets and/or diagnostic and/or prognostic markers by correcting abnormal RhoH expression in a hematopoietic cell.
    Type: Grant
    Filed: September 14, 2016
    Date of Patent: August 18, 2020
    Assignee: Leukemia Therapeutics, LLC
    Inventor: Carl Simon Shelley
  • IDENTIFICATION OF NOVEL DIAGNOSTICS AND THERAPEUTICS BY MODULATING RHOH
    Publication number: 20170074883
    Abstract: The disclosure relates to identifying novel therapeutic targets and/or diagnostic and/or prognostic markers by correcting abnormal RhoH expression in a hematopoietic cell.
    Type: Application
    Filed: September 14, 2016
    Publication date: March 16, 2017
    Applicant: Leukemia Therapeutics, LLC
    Inventor: Carl Simon Shelley